Loading clinical trials...
Loading clinical trials...
A Phase II, Randomized, Double-blind, Multi-center, Placebo-controlled, Dose Optimization, Analog Classroom, Crossover Study Designed to Assess the Time Course of Treatment Effect, Tolerability and Safety of Methylphenidate Transdermal System (MTS) in Pediatric Patients Aged 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD)
Conditions
Interventions
Methylphenidate Transdermal System
Locations
1
United States
UCI Child Development Center
Irvine, California, United States
Start Date
August 1, 2004
Primary Completion Date
May 1, 2005
Completion Date
May 1, 2005
Last Updated
June 25, 2015
NCT07478458
NCT06685601
NCT06910605
NCT05957055
NCT07426302
NCT07339696
Lead Sponsor
Noven Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions